bictegravir
1 January 2025. Related: ARVs and PrEP, Integrase inhibitors
no separate formulation
Integrase inhibitors
Biktarvy: bictegravir/emtricitabine/TAF
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.
cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
1 October 2025. Related: ARVs and PrEP, Integrase inhibitors, NNRTIs
(not to scale)
Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.
Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
cabotegravir-LA (PrEP)
27 October 2025. Related: ARVs and PrEP, Integrase inhibitors, PrEP
Cabotegravir-LA (CAB-LA) is a long acting injection given by intramuscular injections every two months.
dolutegravir
30 August 2024. Related: ARVs and PrEP, Integrase inhibitors
Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.
Dovato (dolutegravir + lamivudine)
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)
elvitegravir
1 May 2018. Related: ARVs and PrEP, Integrase inhibitors
Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.
Generic ARVs
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs
A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.
Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
12 April 2016. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster
Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
Juluca (dolutegravir + rilpivirine)
12 May 2018. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs
raltegravir
3 January 2022. Related: ARVs and PrEP, Integrase inhibitors
Once-daily (600mg) Twice-daily (400 mg)
Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
4 January 2022. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
1 January 2025. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs
Picture not included as there are many different versions.
Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
Triumeq (dolutegravir + abacavir + 3TC)
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
